Application of HCST (hematopoietic cell signal transducer) gene as target to diagnose and treat preeclampsia

作者: Zhang Dongmei , Sun Yaolan

DOI:

关键词:

摘要: The invention belongs to the field of biomedicine and discloses application HCST (hematopoietic cell signal transducer) gene as a target diagnose treat preeclampsia. It is proved by experiment that has significant differences expression in normal placenta tissue preeclampsia tissue. According relevancy preeclampsia, may be used novel molecular marker clinically also drugs.

参考文章(5)
Dae Seog Heo, Kyung Mi Lee, June Chul Lee, Beomseok Suh, Yong Oon Ahn, A possible mechanism of impaired NK cytotoxicity in cancer patients: Down-regulation of DAP10 by TGF-β1 Tumori. ,vol. 97, pp. 350- 357 ,(2011) , 10.1700/912.10124
Jerome Tiollier, Renaud Buffet, Pascale Andre, Marcel Rozencweig, Nk cell modulating treatments and methods for treatment of hematological malignancies ,(2011)
Roman Kischel, Ralf Lutterbüse, Peter Kufer, Katrin Borschert, Robert Hofmeister, Monika Mayer, Gert Riethmüller, Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex ,(2001)
Lewis L. Lanier, Alexander B.H. Bakker, Joseph H. Phillips, Mammalian cell membrane proteins; related reagents ,(1998)
Zezhi Li, Zhenghui Yi, Wu Hong, Yiru Fang, Subsyndromal symptomatic depression gene expression diagnosis chip ,(2011)